Darunavir Tablet, Film Coated
Product Images NDC 70771-1746

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 70771-1746). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Darunavir 600 mg (1b288e91 Dedb 465d 8c45 Eb464dc72e89 01)

Darunavir Tablets 600 mg film-coated tablet label by Zydus Lifesciences Limited. The label indicates a package containing 60 tablets, with warnings including an alert about medicines not to take with Darunavir, child-resistant packaging, and storage instructions. Manufacturer details and dosage referral to prescribing information are also displayed.*

FDA Label Image

Darunavir 800 mg (1b288e91 Dedb 465d 8c45 Eb464dc72e89 02)

Darunavir Tablets 800 mg film-coated oral tablets label from Zydus Lifesciences Limited. The package contains 30 tablets with prescription-only status. The label includes dosage strength, a child-resistant package notice, storage instructions, and a warning to consult about medicines that should not be taken with Darunavir.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.